Lumida
/CNO
⌘K
CNO Financial Group Inc

CNO Financial Group Inc

CNO
$54.94USD-0.16%-0.09 today

MARKET CAP

5.1B

P/E (TTM)

24.7x

FWD P/E

DAY RANGE

$55 – $56

52W RANGE

$38
$58

AI Summary

Stalk
Buy NowMedium

CNO remains in a Stage 2 uptrend with a clear series of higher highs and higher lows. The recent pullback into rising 20-day and 50-day EMAs around the 54 5 zone offers a tactical entry in an otherwise bullish structural context. Short-term momentum is constructive and RSI is neutral, supporting a Buy Now stance despite Bullish Exhaustion signals at the highs.

  • Q2 2026 operating EPS $1.26 (+45% YoY) with 16th straight quarter of sales growth
  • Full-year operating EPS guidance upped to $4.60–$4.80, underscoring strong middle-income demand
  • Increased MedSupp claims risk compressing underwriting margins
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$4.1B$3.6B$4.1B$4.4B$4.5B
YoY %+7.9%-13.2%+15.9%+7.3%+0.9%
P / Sales0.8x0.8x0.8x0.9x0.9x
EV / Sales8.1x9.3x8.5x8.4x8.8x
Gross Profit, Adj.$2.0B$2.0B$1.8B$2.0B$2.0B
YoY %+19.4%-0.5%-7.0%+11.1%-1.5%
Margin %48.2%55.2%44.3%45.9%44.8%
EV / Gross Profit16.8x16.9x19.1x18.3x19.6x
EBITDA, Adj.$1.8B$1.9B$1.6B$1.8B$1.7B
YoY %+299.5%+5.2%-13.7%+12.5%-5.7%
Margin %43.9%53.2%39.6%41.6%38.9%
EV / EBITDA18.4x17.6x21.4x20.2x22.6x
EBIT$1.8B$1.9B$1.6B$1.8B$1.6B
YoY %+299.5%+5.2%-13.7%+12.5%-11.1%
Margin %43.9%53.2%39.6%41.6%36.6%
EV / EBIT18.4x17.6x21.4x20.2x24.0x
Net Income$570.3M$630.6M$276.5M$420.8M$229.3M
YoY %+89.0%+10.6%-56.2%+52.2%-45.5%
Net Margin13.8%17.6%6.7%9.5%5.1%
EPS (GAAP)$4.35$5.36$2.40$3.89$2.30
YoY %+106.2%+23.2%-55.2%+62.1%-40.9%